ClinicalTrials.Veeva

Menu

Light Emitting Diodes With a Continuous Spectrum of 430-780nm for Myopia Prevention

Sun Yat-sen University logo

Sun Yat-sen University

Status

Active, not recruiting

Conditions

Myopia
Refractive Errors
Eye Diseases

Treatments

Device: Novel LEDs

Study type

Interventional

Funder types

Other

Identifiers

NCT05728762
2022KYPJ192

Details and patient eligibility

About

The purpose of this clinical trial is to evaluate the effect of light-emitting diodes (LEDs) with a continuous spectrum of 430-780 nm for lighting in the classroom on myopia prevention among children in Grades 2 and 3.

Full description

Myopia is a common condition that primarily arises in childhood and remains the most important cause of vision loss for children. Irreversible vision-threatening ocular complications such as posterior staphyloma, myopic maculopathy, and glaucoma may occur with a dramatically high risk once myopia progresses to high myopia. Considering the striking rapid increases in the prevalence of myopia and the premature age of myopia onset, myopia prevention is of extreme urgency and presents several challenges.

It has been proven with solid evidence that outdoor times has effects on myopia prevention, which may be attributed to outdoor light exposure. However, it is difficult to meet the required outdoor times (i.e., at least 2 hours/day) for school-aged children under such educational pressure, especially in China. The differences between the light outdoors and indoors in terms of the light spectrum provide some insights into research to find the alternative. The growth rate of the vitreous cavity in juvenile and adult tree shrews grown under red light with a wavelength of 628±10 nm was significantly slower than those grown under the normal fluorescent lighting group, and red light could induce a hyperopic shift in juvenile tree shrews, thus slowing down the development of myopia. Another experiment has also shown that the use of full-spectrum LED covering a continuous spectrum of 400-775 nm accelerated the recovery from form-deprivation myopia in chickens, and it is hypothesized that full-spectrum lighting may affect the choroid-scleral remodeling pathway, which is thought to be associated with myopia control.

The purpose of this study is to evaluate the effects of LEDs covering a continuous spectrum of 430-780 nm for lighting in the classroom (intervention arm) among students in Grades 2 and 3 compared with regular LEDs with a spectrum of 430-630 nm (control arm). Cluster randomization by class was chosen, and all classes in the same school and grade were equally and randomly assigned to the intervention or control arm, with follow-ups at 1- and 2-year. Vision acuity, ocular biometry, cycloplegic refraction, slit-lamp examinations, optical coherence tomography, optical coherence tomography angiography, and questionnaires will be performed at baseline and during the follow-up.

Enrollment

1,920 estimated patients

Sex

All

Ages

7 to 9 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. All the students in Grades 2 and 3 from the 8 schools participated in a myopia surveillance program in Zengcheng District, Guangzhou, China.
  2. Provision of consent and able to participate in all required activities of the study.

Exclusion criteria

  1. Schools without Grade 2 or Grade 3.
  2. Schools that only had one class in either grade.
  3. Children who refused to accept cycloplegia and/or other examinations.
  4. Children with ocular abnormalities and/or previous history of ocular surgery.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

1,920 participants in 2 patient groups

Regular LEDs
No Intervention group
Description:
Students will accept regular LEDs with a spectrum of 430-630 nm for lighting in the classroom.
Novel LEDs
Experimental group
Description:
Students will accept novel LEDs with a spectrum of 430-780 nm for lighting in the classroom.
Treatment:
Device: Novel LEDs

Trial contacts and locations

1

Loading...

Central trial contact

Yizhi Liu

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems